To receive our complimentary newsletters please copy and paste http://www.emergingmarketsllc.com in to your web browser. On the upper right hand corner of the homepage enter your E mail address and click sign up. You will receive a confirmation E mail, click the link and your free subscription will be active.
Verigy, Ltd. was at $26.29 up $5.24 (24.89%) Verigy Ltd. (NASDAQ:VRGY - News), a premier semiconductor test company, yesterday announced that its Board of Directors has approved a share repurchase program. The Board approved the use of up to $150 million to repurchase up to 10 percent of Verigy's outstanding ordinary shares, or approximately 6 million shares, through open market purchases.
About Verigy, Ltd Verigy, Ltd., together with its subsidiaries, designs, develops, manufactures, and sells test systems and solutions for the semiconductor industry in North America, Europe, and the Asia-Pacific. The company offers a 93000 Series platform to test system-on-a-chip (SOC), system-in-a-package (SIP), and memory devices; and Versatest V5000 Series platform to test memory devices, including flash memory and multi chip packages. SOCs and SIPs are semiconductors that integrate the functionality of multiple individual integrated circuits (IC) onto a single IC or package of ICs and contain both digital and analog functionalities, including radio frequency capabilities, communication interfaces, and embedded memory. Verigy also provides consulting, and service and support offerings, such as start-up assistance, application services, and system calibration and repair. Its products are used by semiconductor companies in design validation, characterization, and high volume manufacturing test. The company sells its products and services to integrated device manufacturers; test subcontractors, including specialty assembly, package, and test companies; wafer foundries; and fabless design companies. Verigy is headquartered in Singapore, Singapore.
QLT, Inc. was at $4.59 up $.70 (17.99%) QLT Inc. (NASDAQ: QLTI - News; TSX: QLT - News) today announced that the Board of Directors has formed a Special Committee to review all strategic alternatives available to the Company. The Special Committee, comprised of three independent directors, has appointed Morrison & Foerster, LLP as legal counsel to report directly to the Committee. The Committee has been charged, among other things with the responsibility for exploring alternative ways to maximize shareholder value, including transactions involving the sale of all or part of the assets of the Company.
About QLT, Inc.
QLT, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapies in the fields of ophthalmology and dermatology primarily in the United States, Canada, and Europe. Its approved products include Visudyne, a photosensitizer for the treatment of choroidal neovascularization; Eligard product line for prostate cancer; and Aczone, a dermatology product for the treatment of acne vulgaris. The company's products under development consist of expansion of Visudyne therapy; Eligard 3.75-mg one-month product for the treatment of prostate cancer; Aczone for treating Rosacea; Octreotide Atrigel- three-month product for the treatment of the symptoms of acromegaly; GHRP-1-Atrigel one-month product, a formulation of growth hormone releasing peptide-1 for the treatment of malnutrition in end-stage renal disease patients on hemodialysis; and Risperidone Atrigel- three-month product for the treatment of schizophrenia. In addition, the company has rights to commercialize ForSight Newco II, Inc.'s proprietary ocular punctal plug drug delivery system. The company has collaborative agreements with Novartis Ophthalmics; Sanofi-Synthelabo, Inc.; Medigene AG; Astellas; Han All Pharmaceutical Co.; Key Oncologics; Luxembourg Pharmaceuticals, Ltd.; Mayne Pharma Pty, Ltd.; Ranbaxy Laboratories, Ltd.; Sanofi-Synthelabo, Inc.; and Tecnofarma International, Ltd. QLT was founded in 1981 and is headquartered in Vancouver, Canada.
Freddie Mac was at $29.85 up $4.12 (16.01%) Freddie Mac (FRE) said today that it sold $1.0 billion of one-month reference bills due Dec. 26, 2007, at a stop-out rate, or lowest accepted rate of 4.320 percent. The one-month bills were priced at 99.6640 and have a money market yield of 4.335 percent, according to Freddie Mac. Settlement is Nov. 28.
About Freddie Mac Freddie Mac engages in mortgage purchasing, credit guarantee, and portfolio investment activities in the United States. It purchases single family and multi-family residential mortgages, and mortgage-related securities from lenders in the primary mortgage market that originate mortgages for homebuyers, including mortgage banking companies, commercial banks, savings banks, community banks, credit unions, state and local housing finance agencies, and savings and loan associations. The company also buys mortgage whole loans and mortgage-related securities, and issues guaranteed mortgage-related securities in the secondary market. In addition, it purchases non-securitized mortgage loans and mortgage-related securities for its investments portfolio. Further, Freddie Mac guarantees the payment of principal and interest on mortgage-related securities, including single-class and multi-class structured securities, mortgage participation certificates issued by the company, and securities related to tax-exempt multifamily housing revenue bonds. The company was founded in 1970 and is headquartered in McLean, Virginia.
China Finance Online Co. was at $19.85 up $2.86 (16.83%) China Finance Online Co., Limited (Nasdaq: JRJC - News), a leading Chinese online financial information, data, and analytics provider, today announced that on November 23rd, 2007, it successfully completed the acquisition of 85% equity interest of Daily Growth Investment Company Limited, a licensed securities brokerage firm incorporated in Hong Kong with a history of over 35 years.
About China Finance Online Co.
China Finance Online Co. Limited, through its subsidiaries, engages in selling online financial services analyzing financial and listed company information in the People's Republic of China. It offers subscription-based services based on a single information platform that integrates data and information from various sources with features and functions, such as data and information search, retrieval, delivery, storage, and analysis. The company delivers its features and functions using software tools, which include financial analysis tools that permit users to calculate and analyze quantitatively financial data; current and historical financial data and information for listed company stocks, bonds, and mutual funds; categorized news and research reports; and online forums and bulletin boards. China Finance provides its services to individual investors, institutional investors, high-net worth individuals, investment bankers, stock analysts, financial reporters, and middle class individuals. The company was founded in 1998 and is based in Beijing, the People's Republic of China.
About Emerging Markets Consulting, LLC
Emerging Markets Consulting, LLC is an investor relations and consulting firm serving carefully selected micro cap and small cap clients. Services available include turnkey investor relations services, consulting, marketing and related services needed by publicly traded companies. EMC is unique in that they only work with companies after a stringent due diligence process and they also work with a limited number of clients in order to provide service that is exceptional. The above referenced companies are not clients of Emerging Markets and no compensation has been paid for the exposure provided by this report.
Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned. Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice. Reproduction without written permission is prohibited.
CONTACT: Emerging Markets Consulting, LLC. Tel: +1 321 206 6682 e-mail: jamespainter@emergingmarketsllc.com
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
|
|
